Bempikibart demonstrated durable, clinically meaningful responses in patients with severe alopecia areata in the phase 2 SIGNAL-AA trial.
The post Bempikibart Shows Potential for Hair Regrowth in Alopecia Areata first appeared on Physician’s Weekly.